Xabier Buqué

2.1k total citations
22 papers, 861 citations indexed

About

Xabier Buqué is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xabier Buqué has authored 22 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xabier Buqué's work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Xabier Buqué is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Xabier Buqué collaborates with scholars based in Spain, United States and United Kingdom. Xabier Buqué's co-authors include Patricia Aspichueta, Begoña Ochoa, Carmelo García‐Monzón, María E. Miquilena-Colina, Ainara Cano, Javier Vargas‐Castrillón, Javier González‐Gallego, Sonia Sánchez‐Campos, Elena Lima‐Cabello and María Victoria García‐Mediavilla and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Xabier Buqué

21 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xabier Buqué Spain 11 535 325 258 183 125 22 861
Ryoko Yada Japan 9 603 1.1× 341 1.0× 295 1.1× 170 0.9× 99 0.8× 13 903
Yin-xiong Li China 7 759 1.4× 255 0.8× 385 1.5× 127 0.7× 162 1.3× 14 969
Ainara Cano Spain 13 278 0.5× 231 0.7× 138 0.5× 124 0.7× 75 0.6× 25 589
Sofie M. A. Walenbergh Netherlands 18 505 0.9× 300 0.9× 170 0.7× 94 0.5× 35 0.3× 24 878
Paul G. Thomes United States 19 545 1.0× 254 0.8× 111 0.4× 109 0.6× 161 1.3× 38 942
Claudia Anzivino Italy 12 382 0.7× 279 0.9× 137 0.5× 154 0.8× 101 0.8× 18 852
Francis Sanders United Kingdom 7 375 0.7× 214 0.7× 194 0.8× 158 0.9× 90 0.7× 11 661
Javier Vargas‐Castrillón Spain 10 980 1.8× 397 1.2× 327 1.3× 186 1.0× 151 1.2× 13 1.3k
Benita L. McVicker United States 18 277 0.5× 216 0.7× 67 0.3× 98 0.5× 128 1.0× 50 788
Janne Makkonen Finland 9 634 1.2× 319 1.0× 371 1.4× 326 1.8× 107 0.9× 9 982

Countries citing papers authored by Xabier Buqué

Since Specialization
Citations

This map shows the geographic impact of Xabier Buqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xabier Buqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xabier Buqué more than expected).

Fields of papers citing papers by Xabier Buqué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xabier Buqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xabier Buqué. The network helps show where Xabier Buqué may publish in the future.

Co-authorship network of co-authors of Xabier Buqué

This figure shows the co-authorship network connecting the top 25 collaborators of Xabier Buqué. A scholar is included among the top collaborators of Xabier Buqué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xabier Buqué. Xabier Buqué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buqué, Xabier, Marcel Zimmermann, Hector Flores‐Romero, et al.. (2024). Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells. Cell Communication and Signaling. 22(1). 541–541.
2.
3.
Aurrekoetxea, Igor, et al.. (2023). In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice. Methods in molecular biology. 2675. 1–13. 2 indexed citations
4.
Gómez‐Santos, Beatriz, Diego Sáenz de Urturi, Xabier Buqué, et al.. (2020). Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease. Aging Cell. 19(8). e13183–e13183. 21 indexed citations
5.
Serrano‐Maciá, Marina, Mikel Azkargorta, Jorge Simón, et al.. (2019). FRI-343-NEDDylation inhibition as a new potential therapy of non-alcoholic fatty liver disease. Journal of Hepatology. 70(1). e546–e546. 1 indexed citations
6.
Fernández‐Rodríguez, Conrado, R. Aller, María Luisa Gutiérrez García, et al.. (2019). Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). Revista Española de Enfermedades Digestivas. 111(4). 264–269. 20 indexed citations
7.
Fondevila, Marcos F., Xabier Buqué, Alfonso Mora, et al.. (2018). Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis. Endocrine Abstracts. 1 indexed citations
8.
Barbier‐Torres, Lucía, Teresa C. Delgado, Paula Iruzubieta, et al.. (2018). The liver-specific deletion of the respiratory chain inhibitor MCJ attenuates NAFLD progression by enhancing hepatic betaoxidation. Journal of Hepatology. 68. S362–S362. 1 indexed citations
9.
Gómez‐Santos, Beatriz, Diego Sáenz de Urturi, Xabier Buqué, et al.. (2018). Atorvastatin provides a new lipidome improving early regeneration after partial hepatectomy in osteopontin deficient mice. Scientific Reports. 8(1). 14626–14626. 2 indexed citations
10.
Porteiro, Begoña, Marcos F. Fondevila, Xabier Buqué, et al.. (2017). Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis. Molecular Metabolism. 8. 132–143. 28 indexed citations
11.
Gómez‐Santos, Beatriz, Xabier Buqué, Juan L. García‐Rodríguez, et al.. (2017). Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver. Journal of Lipid Research. 58(9). 1903–1915. 24 indexed citations
12.
Cristóbal, Susana, Sara Tedesco, Narges Bayat, et al.. (2015). Proteomic and lipidomic analysis of primary mouse hepatocytes exposed to metal and metal oxide nanoparticles. KTH Publication Database DiVA (KTH Royal Institute of Technology). 5(1). 6 indexed citations
13.
Martinez‐Uña, Maite, Marta Varela‐Rey, Olatz Fresnedo, et al.. (2014). S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. Journal of Hepatology. 62(3). 673–681. 41 indexed citations
14.
Maldonado, Eduardo N., Igotz Delgado, Natalia E. Furland, et al.. (2014). The E2F2 Transcription Factor Sustains Hepatic Glycerophospholipid Homeostasis in Mice. PLoS ONE. 9(11). e112620–e112620. 7 indexed citations
15.
Martinez‐Uña, Maite, Marta Varela‐Rey, Ainara Cano, et al.. (2013). Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology. 58(4). 1296–1305. 89 indexed citations
16.
Bravo, Elena, Simonetta Palleschi, Patricia Aspichueta, et al.. (2011). High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. Lipids in Health and Disease. 10(1). 60–60. 70 indexed citations
17.
Miquilena-Colina, María E., Elena Lima‐Cabello, Sonia Sánchez‐Campos, et al.. (2011). Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 60(10). 1394–1402. 359 indexed citations
18.
Cano, Ainara, Xabier Buqué, Maite Martinez‐Uña, et al.. (2010). Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. Hepatology. 54(6). 1975–1986. 69 indexed citations
19.
Buqué, Xabier, María José Martínez, Ainara Cano, et al.. (2009). A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. Journal of Lipid Research. 51(3). 500–513. 68 indexed citations
20.
Buqué, Xabier, Patricia Aspichueta, & Begoña Ochoa. (2008). Fundamento molecular de la esteatosis hepática asociada a la obesidad. Revista Española de Enfermedades Digestivas. 100(9). 565–78. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryoko Yada Breakdown of academic impact, for papers by Yin-xiong Li Breakdown of academic impact, for papers by Ainara Cano Breakdown of academic impact, for papers by Sofie M. A. Walenbergh Breakdown of academic impact, for papers by Paul G. Thomes Breakdown of academic impact, for papers by Claudia Anzivino Breakdown of academic impact, for papers by Francis Sanders Breakdown of academic impact, for papers by Javier Vargas‐Castrillón Breakdown of academic impact, for papers by Benita L. McVicker Breakdown of academic impact, for papers by Janne Makkonen
Rankless by CCL
2026